LG Chem Introduces Asimov's AI-Based Cell Line Development Platform

LG Chem Introduces CHO Edge System Including Asimov’s Latest Chrysalis Transposase and AI-Based Gene Design Software Kernel… to be Used in Biopharmaceutical Cell Line Development

Boston, USA (GLOBE NEWSWIRE) - Asimov, a developer of AI-based synthetic biology platforms for therapeutic development, announced that it has signed a licensing agreement with LG Chem, a global chemical company with a diverse business portfolio in the fields of petrochemicals, advanced materials, and life sciences. Through this agreement, LG Chem plans to license Asimov's CHO Edge System and utilize it for the development of biopharmaceutical cell lines.

Alec Nielsen, co-founder and CEO of Asimov, said, “As drug developers explore a much broader range of therapeutic design areas than before, the development of biopharmaceuticals with complex structures, such as multispecific antibodies, fusion proteins, and antibody-drug conjugates (ADCs), is rapidly increasing. LG Chem is leading this trend of innovation, and we consider it very meaningful to have selected and adopted Asimov’s CHO Edge System as a core foundational technology for the development of next-generation biopharmaceuticals.”

Introduction to Asimov
Asimov aims to accelerate the implementation of biotechnologies capable of creating significant social value by advancing humanity's capacity to design life systems. Asimov develops synthetic biology platforms ranging from cells to software and supports the design and production of next-generation therapies, including biopharmaceuticals, cell and gene therapies, and RNA therapies, through products, services, and various collaborations.

Asimov was founded by biotechnologists from MIT and Boston University and is headquartered in Boston, USA. It has raised over $200 million in investment to date from major institutional investors, including Andreessen Horowitz, CPP Investments, Horizons Ventures, and Fidelity Management & Research Company. Further details can be found on the official Asimov website ( https://www.asimov.com ).

Introduction to LG Chem and LG Chem Life Sciences Business Division
LG Chem is a global chemical company with a diverse business portfolio spanning petrochemicals, advanced materials, and life sciences. LG Chem Life Sciences focuses on developing and supplying innovative medicines across various therapeutic areas.

LG Chem Life Sciences provides differentiated solutions to customers based on its mission to transform people's lives through scientific discovery and leading innovation. Further details can be found on the official LG Chem website ( https://www.lgchem.com ).